Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
paclitaxel (taxol) (1 trial)
Carcinoma, Transitional Cell (Phase 2)
Neoplasms (Phase 2)
Urinary Bladder Diseases (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Urogenital Neoplasms (Phase 2)
Urologic Diseases (Phase 2)
Urologic Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (1 total)